BLAU3.SA SAO
Blau Farmacêutica S.A.
1W: +6.2%
1M: +11.5%
3M: +7.3%
YTD: +10.1%
1Y: -4.8%
3Y: -30.5%
5Y: -72.0%
R$10.84 ($2.07)
+0.10 (+0.93%)
Weekly Expected Move ±3.4%
R$10
R$10
R$11
R$11
R$12
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$222M
-56.2% ▼
5Y CAGR: -0.1%
Capital Expenditures
$262M
-85.7% ▼
5Y CAGR: +8.9%
Free Cash Flow
-$40M
-110.9% ▼
Dividends Paid
$82M
-46.1% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$12M
+574.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $482M | $469M | $250M | $292M | $295M |
| Depreciation & Amort. | $21M | $22M | $39M | $52M | $64M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$197M | -$237M | -$5M | $100M | -$215M |
| Other Non-Cash Items | -$152M | -$82M | -$95M | $64M | $78M |
| Operating Cash Flow | $154M | $172M | $188M | $507M | $222M |
| — Investing Activities — | |||||
| Capital Expenditures | -$178M | -$143M | -$115M | -$143M | -$419M |
| Acquisitions (Net) | $0 | $0 | -$137M | $35K | $0 |
| Investment Purchases | -$693M | $0 | -$265M | $0 | -$67M |
| Investment Sales | $0 | $313M | $309M | $0 | $0 |
| Other Investing | -$14K | -$37M | -$149M | -$172M | $331M |
| Investing Cash Flow | -$870M | $133M | -$357M | -$315M | -$155M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$379M | -$86M | $277M | -$50M | $42M |
| Stock Repurchased | -$26M | -$81M | -$3M | -$2M | $0 |
| Dividends Paid | -$104M | -$136M | -$66M | -$56M | -$82M |
| Other Financing | -$8M | -$40M | -$40M | -$83M | -$12M |
| Financing Cash Flow | $698M | -$343M | $186M | -$191M | -$52M |
| Net Change in Cash | -$18M | -$38M | $17M | $2M | $12M |
| Cash End of Period | $52M | $14M | $31M | $33M | $46M |
| Free Cash Flow | -$24M | -$8M | $106M | $366M | -$40M |